Oaktree Acquisition Corp. III Life Sciences (OACCW) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 1.42M | 1.48M | 1.56M | 1.56M | 0 |
| Cash & Short-Term Investments | - | - | - | - | - |
| Cash Only | - | - | - | - | - |
| Short-Term Investments | - | - | - | - | - |
| Accounts Receivable | - | - | - | - | - |
| Days Sales Outstanding | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Days Inventory Outstanding | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 203.41M | 199.77M | 197.61M | 193.69M | 638.99K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 203.41M | 199.77M | 197.58M | 193.58M | 0 |
| Other Non-Current Assets | - | - | - | - | - |
| Total Assets | 204.83M | 201.25M | 199.18M | 195.25M | 638.99K |
| Asset Turnover | - | - | - | - | - |
| Asset Growth % | - | 31394.91% | - | - | - |
| Total Current Liabilities | 1.62M | 1.23M | 1.12M | 727.32K | 662.09K |
| Accounts Payable | 0 | 414.11K | 381.55K | 0 | 0 |
| Days Payables Outstanding | - | - | - | - | - |
| Short-Term Debt | 11.82K | 11.82K | 11.82K | 11.82K | 109.41K |
| Deferred Revenue (Current) | - | - | - | - | - |
| Other Current Liabilities | 1.61M | 0 | 0 | 715.5K | 545.75K |
| Current Ratio | 0.87x | 1.21x | 1.39x | 2.14x | - |
| Quick Ratio | 0.87x | 1.21x | 1.39x | 2.14x | - |
| Cash Conversion Cycle | - | - | - | - | - |
| Total Non-Current Liabilities | 7.02M | 7.02M | 7.02M | 7.02M | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | - | - | - | - | - |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Liabilities | 8.64M | 8.25M | 8.14M | 7.75M | 662.09K |
| Total Debt | 11.82K | 11.82K | 11.82K | 11.82K | 109.41K |
| Net Debt | -1.27M | -1.32M | -1.37M | -1.35M | 109.41K |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | - |
| Debt / EBITDA | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - |
| Total Equity | 196.19M | 193M | 191.04M | 187.5M | -23.09K |
| Equity Growth % | - | 835797.89% | - | - | - |
| Book Value per Share | 10.22 | 10.05 | 7.77 | 7.63 | -0.00 |
| Total Shareholders' Equity | 196.19M | 193M | 191.04M | 187.5M | -23.09K |
| Common Stock | 203.41M | 199.77M | 197.58M | 193.58M | 503 |
| Retained Earnings | -7.23M | -6.77M | -6.54M | -6.08M | -48.09K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |